You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 1, January 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Excimer Laser Ablation of Infectious Crystalline Keratopathy

Richard A. Eiferman, MD; Dean R. Forgey, MD; Yvonne D. Cook, COT
Louisville, Ky

Arch Ophthalmol. 1992;110(1):18.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Infectious crystalline keratopathy is an uncommon infection caused by a variety of streptococci.1 We report herein the successful use of the excimer laser to eradicate a case of intractable disease.

Report of a Case.

—A 68-year-old white woman wore extended-wear contact lenses for correction of aphakia. She developed fernlike opacities in the anterior stroma without evidence of ocular inflammation (Fig 1). Cultures and scrapings revealed no growth and a presumptive diagnosis of infectious crystalline keratopathy was made. The patient was administered topical vancomycin hydrochloride without any clinical response. Because of the superficial location of the lesions, we attempted to eradicate her infection with the excimer laser under a Phase II-B protocol that has been approved by the Food and Drug Administration.

A peribulbar block was administered using 4% Xylocaine (lidocaine), and the patient was aligned under a 193-nm argon fluoride excimer laser (Taunton LV 2000, Taunton Technologies, Monroe, Conn). . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.